Recombinant human erythropoietin attenuates hepatic injury induced by ischemia/reperfusion in an isolated mouse liver model.
Hochhauser, Edith
Recombinant human erythropoietin attenuates hepatic injury induced by ischemia/reperfusion in an isolated mouse liver model. [electronic resource] - Apoptosis : an international journal on programmed cell death Jan 2008 - 77-86 p. digital
Publication Type: Journal Article
1360-8185
10.1007/s10495-007-0155-8 doi
Animals
Apoptosis--drug effects
Caspase 3--metabolism
Disease Models, Animal
Erythropoietin--pharmacology
Humans
Ischemia
Liver--blood supply
MAP Kinase Kinase 4--metabolism
Male
Mice
Protein Serine-Threonine Kinases--metabolism
Random Allocation
Recombinant Proteins
Reperfusion
Reperfusion Injury--metabolism
von Willebrand Factor--metabolism
NF-kappaB-Inducing Kinase
Recombinant human erythropoietin attenuates hepatic injury induced by ischemia/reperfusion in an isolated mouse liver model. [electronic resource] - Apoptosis : an international journal on programmed cell death Jan 2008 - 77-86 p. digital
Publication Type: Journal Article
1360-8185
10.1007/s10495-007-0155-8 doi
Animals
Apoptosis--drug effects
Caspase 3--metabolism
Disease Models, Animal
Erythropoietin--pharmacology
Humans
Ischemia
Liver--blood supply
MAP Kinase Kinase 4--metabolism
Male
Mice
Protein Serine-Threonine Kinases--metabolism
Random Allocation
Recombinant Proteins
Reperfusion
Reperfusion Injury--metabolism
von Willebrand Factor--metabolism
NF-kappaB-Inducing Kinase